Literature DB >> 2782938

Treatment for refractory myasthenia gravis.

T Sakano1, T Hamasaki, Y Kinoshita, M Kihara, K Ueda.   

Abstract

An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immunoglobulin and high dose intravenous methylprednisolone. Ocular symptoms recurred seven months after the start of the immunoglobulin. She has been in remission for more than 12 months after two courses of intravenous methylprednisolone, and administration of oral prednisolone was discontinued.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2782938      PMCID： PMC1792514          DOI： 10.1136/adc.64.8.1191

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  3 in total

1.  Thymectomy as primary therapy in myasthenia gravis.

Authors:  C W Olanow; A S Wechsler; M Sirotkin-Roses; J Stajich; A D Roses
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

2.  High-dose intravenous immunoglobulin in the management of myasthenia gravis.

Authors:  E L Arsura; A Bick; N G Brunner; T Namba; D Grob
Journal:  Arch Intern Med       Date:  1986-07

3.  High-dose intravenous methylprednisolone in myasthenia gravis.

Authors:  E Arsura; N G Brunner; T Namba; D Grob
Journal:  Arch Neurol       Date:  1985-12
  3 in total
  2 in total

1.  Atopy, bronchial responsiveness, and symptoms in wheezy 3 year olds.

Authors:  N M Wilson; S B Phagoo; M Silverman
Journal:  Arch Dis Child       Date:  1992-04       Impact factor: 3.791

2.  Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.

Authors:  M Ichikawa; C S Koh; Y Hata; M Tohyama; T Tsuno; A Komiyama
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.